Implantable Glucose Sensors With Thin Membranes for Long-Term Monitoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional glucose sensors face challenges due to limited surface area and volume, leading to sensor agent depletion, poor signal-to-noise ratios, and short operational lifespans, exacerbated by foreign body responses and diffusion delays, necessitating improved systems for long-term continuous glucose monitoring.
Innovation Solution
The development of enzymatic electrochemical glucose sensors with increased surface areas and optimized membrane thickness, positioned within fluid-filled lumens, maintaining high signal-to-noise ratios and reducing amperage decay, allowing for extended operation without recharging, up to two years.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If the surface area and volume of the sensing element are reduced to prevent insertion pain and wearer discomfort, then user comfort is improved, but the amount of glucose sensing agent that can be incorporated is limited, leading to sensor output diminishment over time
Solution Approach 1:
The patent changes the physical and chemical parameters of the sensing element, including using a flexible substrate with specific surface area ranges (0.01 to 0.5 cm²) and incorporating specific amounts of glucose oxidase (1 to 100 μg/cm²). The membrane thickness is optimized (1 to 10 μm) to balance diffusion rate and enzyme capacity, allowing the sensor to maintain stable output over extended periods while remaining comfortable for wearers.
Solution Approach 2:
The sensing element employs a composite structure consisting of a flexible substrate, enzyme layer (glucose oxidase), and semi-permeable membrane. This composite design allows integration of multiple functions: mechanical flexibility for comfort, enzymatic activity for glucose detection, and controlled diffusion for signal stability. The combination of materials enables the sensor to achieve both user comfort and reliable long-term operation.
2Measurement precision
If the surface area of the sensing element is increased to increase the sensor current level, then signal-to-noise ratio is improved, but the sensor size and volume increase, introducing pain and/or discomfort to the user
Solution Approach 1:
The patent optimizes the surface area parameter to a specific range (0.01 to 0.5 cm²) that balances signal generation capability with wearability. This parameter optimization ensures sufficient glucose oxidase loading (1 to 100 μg/cm²) to generate adequate current signal while maintaining small physical dimensions for user comfort. The membrane thickness (1 to 10 μm) is also tuned to achieve optimal diffusion rates that enhance signal stability without requiring larger sensor面积.
3Duration of action of moving object
If the membrane thickness is increased to accommodate more glucose oxidase, then sensor life is extended, but diffusion delays occur resulting in clinically unacceptable lag time
Solution Approach 1:
The membrane thickness is precisely controlled within the range of 1 to 10 μm to achieve optimal balance between enzyme capacity and diffusion rate. This thin membrane configuration allows sufficient glucose oxidase loading (1 to 100 μg/cm²) to extend sensor operational life while maintaining diffusion times that meet clinical requirements. The semi-permeable nature of the membrane further optimizes glucose transport while protecting the enzyme layer.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The sensors provide stable glucose level monitoring with minimal amperage decay and time delays, ensuring accurate and consistent glucose measurements over an extended period, addressing the limitations of conventional sensors.
Implementation Method 1
an electrode configured to generate a current; and, an electronics assembly... wherein the current is indicative of the glucose level
Implementation Method 2
the diffusion rate can only be decreased to a certain level before sensor measurements (current levels) approach a minimum acceptable signal-to-noise ratio
Data Source
AI summary
A device for continuously monitoring glucose levels in a patient includes a lead assembly in electrical communication with an electronics assembly. The electronics assembly is configured to be positioned in the subcutaneous tissue and the lead assembly is configured to be positioned in a vessel of the patient, such as in a vein or in an epidural space. The lead assembly has a lumen, and includes at least one electrode in electrical communication with the electronics assembly.